PMID- 19337526 OWN - NLM STAT- MEDLINE DCOM- 20090716 LR - 20240419 IS - 1552-9924 (Electronic) IS - 0091-6765 (Print) IS - 0091-6765 (Linking) VI - 117 IP - 3 DP - 2009 Mar TI - A physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies. PG - 481-7 LID - 10.1289/ehp.0800047 [doi] AB - BACKGROUND: It has been suggested that pre- and postnatal exposure to persistent organic pollutants (POPs) can promote several adverse effects in children, such as altered neurodevelopment. Epidemiologic studies to date have relied on the analysis of biological samples drawn pre- or post-natally for exposure assessment, an approach that might not capture some key events in the toxicokinetics of POPs. OBJECTIVES: We aimed to build a generic physiologically based pharmacokinetic (PBPK) modeling framework for neutral POPs to assess infant toxicokinetic profiles and to validate the model using data on POP levels measured in mothers and infants from a Northern Quebec Inuit population. METHODS: The PBPK model developed herein was based upon a previously published model to which an infant submodel was added. Using the model and maternal blood levels at the time of delivery, exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE), 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (p,p'-DDT), hexachlorobenzene (HCB), beta-hexachlorocyclohexane (beta-HCH), 2,2',3,4,4',5'-hexachlorobiphenyl (PCB-138), 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153), and 2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB-180) in mothers was estimated to subsequently simulate infant blood, breast milk, and cord blood POP concentration. Simulations were then compared with corresponding measured levels through Spearman correlation analyses. RESULTS: Predictions were highly correlated with measured concentrations for PCB-153, PCB-180, PCB-138, HCB, and p,p'-DDE (r = 0.83-0.96). Weaker correlations were observed for p,p'-DDT and beta-HCH for which levels were near the limits of detection. CONCLUSION: This is the first study to validate a PBPK model of POPs in infants on an individual basis. This approach will reduce sampling efforts and enable the use of individualized POP toxicokinetic profiles in the epidemiologic studies of POP adverse effects on child development. FAU - Verner, Marc-Andre AU - Verner MA AD - Departement des sciences biologiques, Centre Toxen, Universite du Quebec a Montreal, and Centre de recherche du Hospitalier Universitaire de Quebec, Montreal, Quebec, Canada. FAU - Ayotte, Pierre AU - Ayotte P FAU - Muckle, Gina AU - Muckle G FAU - Charbonneau, Michel AU - Charbonneau M FAU - Haddad, Sami AU - Haddad S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20081110 PL - United States TA - Environ Health Perspect JT - Environmental health perspectives JID - 0330411 RN - 0 (Environmental Pollutants) RN - 0 (Organic Chemicals) SB - IM EIN - Environ Health Perspect. 2013 Jul;121(7):A209 MH - Adult MH - Computer Simulation MH - Environmental Pollutants/blood/*pharmacokinetics MH - *Epidemiologic Methods MH - Female MH - Humans MH - Infant MH - Inuit MH - *Maternal Exposure MH - *Models, Biological MH - Organic Chemicals/blood/*pharmacokinetics MH - Quebec PMC - PMC2661921 OTO - NOTNLM OT - epidemiology OT - exposure assessment OT - infants OT - persistent organic pollutants OT - physiologically based pharmacokinetic modeling EDAT- 2009/04/02 09:00 MHDA- 2009/07/17 09:00 PMCR- 2009/03/01 CRDT- 2009/04/02 09:00 PHST- 2008/07/28 00:00 [received] PHST- 2008/11/10 00:00 [accepted] PHST- 2009/04/02 09:00 [entrez] PHST- 2009/04/02 09:00 [pubmed] PHST- 2009/07/17 09:00 [medline] PHST- 2009/03/01 00:00 [pmc-release] AID - ehp-117-481 [pii] AID - 10.1289/ehp.0800047 [doi] PST - ppublish SO - Environ Health Perspect. 2009 Mar;117(3):481-7. doi: 10.1289/ehp.0800047. Epub 2008 Nov 10.